title: Recent highlights in anti-protozoan drug development and resistance research.
abstract: This article summarizes the highlights of research presented in January, 2012, at the Keystone Symposium on "Drug Discovery for Protozoan Parasites" held in Santa Fe, New Mexico. This symposium which convenes approximately every 2 years provides a forum for leading investigators around the world to present data covering basic sciences to clinical trials relating to anti-protozoan drug development and drug resistance. Many talks focused on malaria, but other protozoan diseases receiving attention included African sleeping sickness, Chagas disease, leishmaniasis, cryptosporidiosis, and amoebiasis. The new research, most of it unpublished, provided insights into the latest developments in the field.
authors.affiliation: Department of Medicine, University of Washington, Seattle, WA 98195-7185, United States.
authors.forename: Frederick S
authors.initials: FS
authors.lastname: Buckner
authors.affiliation: Department of Chemistry and Life Science, United States Military Academy, West Point, NY 10996, United States.
authors.forename: Norman C
authors.initials: NC
authors.lastname: Waters
authors.affiliation: Discovery Biology, Griffith University, Nathan, Queensland 4111, Australia.
authors.forename: Vicky M
authors.initials: VM
authors.lastname: Avery
keywords: Antiparasitic drug discovery; Drug resistance; Malaria; Protozoa